Position in LLY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$14,202,451
+$5,039,703 QoQ
Shares Held
11,841
+18.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
#1,062
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EQUITABLE TRUST CO holds $57,380,169 across 10 Drug Manufacturers - General names. LLY ranks #1 (24.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
11,841 | $14,202,451 | |
| 2 | JNJ |
Johnson & Johnson
|
51,986 | $13,202,883 | |
| 3 | ABBV |
AbbVie Inc.
|
35,598 | $8,957,880 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
49,624 | $6,269,495 | |
| 5 | MRK |
Merck & Co., Inc.
|
47,528 | $6,107,348 | |
| 6 | NVS |
Novartis AG
|
26,861 | $4,209,655 | |
| 7 | AMGN |
Amgen Inc
|
4,866 | $1,762,075 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
20,829 | $1,200,166 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,202,451 | 11,841 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $9,162,748 | 9,962 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $11,098,221 | 10,327 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $6,105,526 | 8,002 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $6,478,673 | 8,311 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $6,956,639 | 8,423 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $6,606,004 | 8,557 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $7,565,926 | 8,540 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $7,708,405 | 8,514 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $6,622,772 | 8,513 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $5,153,012 | 8,840 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $4,780,456 | 8,900 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $4,091,850 | 8,725 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $3,070,173 | 8,940 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $3,213,537 | 8,784 | Shares | Sole | 2023-02-17 | |
| 2022-09-30 | $3,189,201 | 9,863 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $3,500,386 | 10,796 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $3,264,903 | 11,401 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $3,223,210 | 11,669 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $2,716,223 | 11,756 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $2,849,490 | 12,415 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $2,261,828 | 12,107 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,626,097 | 9,631 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,425,580 | 9,631 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,581,217 | 9,631 | Shares | Sole | 2020-08-18 | |
| 2020-03-31 | $1,369,027 | 9,869 | Shares | Sole | 2020-05-21 | |
| No filing history on record for this holder in this stock. | ||||||